Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Noninvasive radiofrequency sensor with machine learning may accurately measure glucose
NEW ORLEANS —A noninvasive device using a radiofrequency sensor may be able to measure glucose levels for people with diabetes in the future, according to a speaker at the AACE Annual Meeting.
Referral program boosts postpartum visits to primary care during year after delivery
Women with gestational diabetes or hypertension referred from obstetrics to a primary care provider after delivery were six times more likely to attend a visit with a PCP in the first year postpartum, data show.
Log in or Sign up for Free to view tailored content for your specialty!
AI, new technology major focus at 2024 AACE annual meeting
Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.
VIDEO: Cardiovascular benefits of GLP-1 agonists ‘absolutely stunning’
BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.
Important updates in cardiology from Clyde W. Yancy, MD, MSc
BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.
GLP-1 receptor agonist use not linked to respiratory complication risk after surgery
Among patients with diabetes undergoing emergency surgery, the risk for respiratory complications afterward was not heightened with glucagon-like peptide-1 receptor agonist use, according to a research letter published in JAMA.
GLP-1 receptor agonist tied to similar thyroid cancer risk as DPP-IV, SGLT2 inhibitors
Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.
Combined insomnia, OSA phenotype predicts incident diabetes in men
In older men, the sleep breathing impairment index definition of combined insomnia-obstructive sleep apnea predicted incident diabetes, according to results published in Annals of the American Thoracic Society.
Fully-implantable CGM receives FDA authorization for integration with insulin pumps
The FDA granted integrated continuous glucose monitoring designation to a fully-implantable CGM, according to a press release.
Most US adults estimated to have subclinical cardiovascular-kidney-metabolic syndrome
More than 70% of the overall U.S. population is estimated to have subclinical cardiovascular-kidney-metabolic syndrome, according to a research letter published in the Journal of the American College of Cardiology.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read